Member Info for SYN00GOLD

Popeye : I agree with you, I can offload 500,000 @ 11.4p currently with HL. My point is I think in relative terms, we will have to wait for that 4.99% holding to dwindle a little more.

I think quite a lot still being offloaded on the quiet holding us back !!! Expecting this to be static now till news.

Take the 30p and run for your life !!!!!!!!!!!!!!!

THIS IS OVER

ALTERNATIVE IS NOTHING - See HARL as example............

I think you will be very happy come the conclusion of said deals announced by Tim : we just await the news 🎁🎁🙏🥳👀👀🎅🎅🎅🎅🎅

MASSIVE upgrade this month. Anticipate 20p without news 🎁🎁🎁🎁🎁👀

2 words :

Exponential Growth !!!!!🎁🥳🎉

Correct Roger and spot on analysis, day to day does not matter,

Think this is dropping today into 10-11 range, the focus should be on the release of the big news of deals !!

Not looking at these bl00dy charts again !!

https://uk.investing.com/equities/immupharma-plc-technical

Expecting attack on 15s next

Https://www.investing.com/equities/immupharma-plc-technical

STRONG BUY !!!!!

.

Wish you great things halfbutt : I know you have been invested a long time !!

Quite a few, my average was 2p a month ago and now my average is 5.9p !!!!!

I sold quite a chunk when we 1st had the big rise to 8p, that was a mistake in hindsight 😂

Looking forward to a life changing result here.

Can now buy again, picked up another 150,000 @ 13.2p, not showing though ??

Van't buy any atm on HL, but can sell a lot at 12.9p 🤔🎁😊🚀🚀🚀🚀🚀🚀🚀🎅🎅🎅🎅🎅🎅🎄🎄🎄🎄🎄

OTM : I really have to filter you, Goodbye

You have an entire life to be an idiot. Why not take today off?

Recap:

IMM has announced a groundbreaking patent for its lead asset P140, the world’s first “Immunormalizer,” offering a precision diagnostic and treatment approach for autoimmune diseases. With potential 20-year exclusivity, the patent targets patients with the newly identified “Type M” immune disorder, who are super-responders to P140, opening the door to safer, more effective therapies across up to 50 autoimmune conditions. This dual opportunity as both a first-in-class therapy and novel diagnostic test positions ImmuPharma at the forefront of a $100bn treatment and $10bn diagnostics market.

IMM and P140 could transform the landscape of autoimmune disease management.

Discussions ongoing with pharma currently under NDA agreements. Due Diligence will be underway by numerous parties.

Let's see which is the special RNS before end of 2025

https://audioboom.com/posts/8772192-midweek-takeaway-featuring-tim-mccarthy-ceo-and-dr-sebastien-goudreau-newly-appointed-cso-of

Just listen carefully............................🎁🎁🎁🎁😊

Hello Golden Cross my old friend,

Just bought 4 #'s totaling 240,000 shares, bargain basement, ignore the nonsense 🎁

Https://www.google.com/search?q=uniqure+share+price&rlz=1C1GCEA_enGB1149GB1150&oq=&gs_lcrp=EgZjaHJvbWUqCQgDEEUYOxjCAzIJCAAQRRg7GMIDMgkIARBFGDsYwgMyCQgCEEUYOxjCAzIJCAMQRRg7GMIDMhEIBBAAGAMYQhiPARi0AhjqAjIRCAUQABgDGEIYjwEYtAIY6gIyEQgGEAAYAxhCGI8BGLQCGOoCMhEIBxAAGAMYQhiPARi0AhjqAtIBCTUwMzlqMGoxNagCCLACAfEFgAE5Z31qhF_xBYABOWd9aoRf8QWAATlnfWqEXw&sourceid=chrome&ie=UTF-8

This was after just a pivotal Phase 1/2 study. Brilliant news for Huntingdons disease.

I believe we will see an explosion in share price when 1st deal is announced for p140 for IMM

Stay strong and ignore FUD !!!